Wird geladen...
The promise of epigenomic therapeutics in pancreatic cancer
Pancreatic ductal adenocarcinoma (PDAC) is often viewed to arise primarily by genetic alterations. However, today we know that many aspects of the cancer phenotype require a crosstalk among these genetic alterations with epigenetic changes. Indeed, aberrant gene expression patterns, driven by epigen...
Gespeichert in:
| Veröffentlicht in: | Epigenomics |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Future Medicine Ltd
2016
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5066125/ https://ncbi.nlm.nih.gov/pubmed/27337224 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/epi-2015-0016 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|